There were no significant differences in the mRNA expression of these other target genes between transcriptomic groups save for higher CDK6 expression in CDKN2Ahigh meningiomas in the Bayley et al. cohort (Supplementary Fig. 5b). This evidence concerns the gene CDK6 and meningioma.